Is Coxsackievirus Behind the Surge in Type 1 Diabetes?
Explore how Coxsackievirus may be linked to the rise in Type 1 diabetes by triggering autoimmune responses in genetically predisposed individuals.
September 25, 2024
Semaglutide and SGLT2 Inhibitors at EASD 2024: Insights into Cardiovascular Benefits and Challenges
Explore the latest EASD 2024 findings on semaglutide’s heart health benefits and challenges with SGLT2 inhibitors in diabetes management.